APAC Veterinary Diagnostics Market

APAC Veterinary Diagnostics Market Size (2022 to 2027)

The size of the veterinary diagnostics market in the Asia-Pacific region is expected to be growing at a prominent CAGR during the forecast period.

In recent years, it has seen a tectonic shift with the emergence of new and technologically advanced products, which had an optimistic impact on the market's overall growth.

Diagnostics provide tools for effective and rapid testing to undertake preventative or remedial measures for the health of the animal population. For instance, lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock (large animals - cows, poultry, sheep, pigs, etc.) and household pets (cats, dogs, etc.) to check for the presence of a variety of medical conditions caused by bacteria, viruses, allergies, and fertility issues. Food animal diagnostics assist livestock and production of animal preventive care and complement other measures such as vaccination and selective breeding.

Immunodiagnostics is expected to grow at a higher CAGR due to the increase in the number of foodborne diseases affecting the animals resulting in the increasing need to perform various tests. The market for Molecular diagnostics is also expected to grow due to the broad scope it provides over the likes of immunodiagnostics. In addition, an increase in purchase and usage of various diagnostic instruments utilized in veterinary practices, in-clinic diagnostic procedures, high-income households that keep pets, and regularly visit veterinary laboratories are propelling the growth of this market.

However, increasing the adoption of vegetarian food due to changing food habits, the economic downturn, the increasing risk of obesity, exposure to global cuisines are factors affecting the growth.

This research report on the APAC veterinary diagnostics market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Clinical Chemistry
  • Urine Analysis
  • Glucose Monitoring
  • Blood Gas Electrolyte Analysis
• Molecular Diagnostics        
  • Micro Arrays
  • PCR Tests
  • Other Molecular Diagnostics Tests
• Hematology         
  • Hematology Analysers
  • Hematology Cartridges
• Diagnostic Imaging              
  • Radiography Systems
  • Ultrasound Imaging Systems
  • CT Scanners
  • MRI Scanners
• Immunodiagnostics            
  • Immunoassay Analysers
  • ELISA Tests
  • Lateral-Flow Strip Readers
  • Lateral-Flow Rapid Tests
  • Allergen-specific Immunodiagnostic Tests

By Animals: 

• Companion Animals            
  • Canine Diagnostics
  • Feline Diagnostics
  • Other Veterinary Diagnostics
• Food-Producing Animals   
  • Bovine Diagnostics
  • Porcine Diagnostics
  • Ovine Diagnostics
  • Poultry Diagnostics
  • Piscine Diagnostics

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

In the Asia-Pacific market, animal diseases are a significant and increasingly important factor in reducing livestock productivity, especially in developing countries like India. While in many areas, traditional methods are still widely used, most of them turn out to be ineffective or too slow to directly influence the clinical management of a particular case, providing results after several days. Thus, the focus in the development of animal disease diagnostics has been toward rapid methods that can give a conclusive answer.

The Asia-Pacific veterinary diagnostics market is segmented by products, types of animals, and geography. The veterinary diagnostics market is mainly categorized by-products into clinical chemistry, molecular diagnostics, hematology analyzers, diagnostic imaging, immunodiagnostics, etc. The animal market covers companion animals and food-producing animals.

KEY MARKET PLAYERS:

Companies playing a significant role in the APAC veterinary diagnostics market profiled in this report are VCA Inc., Heska Corporation, Abaxis Inc., VIRBAC, IDEXX Laboratories Inc., Life Technologies Corporation, Bio-Rad Laboratories Inc., Prionics AG, and Pfizer. Inc.